-
Goldman Sachs Upgrades Chemours On Improving End Markets
Wednesday, June 9, 2021 - 12:37pm | 283Read More...Chemours Co.’s (NYSE: CC) near-term prospects are now brighter, driven by TiO2 cycle improvement and growth in the Fluoroproducts business due to a cyclical recovery and secular trends, according to Goldman Sachs. The Chemours Analyst: Robert Koort upgraded the rating for Chemours from...
-
FMC Corp. Picks Up Sell-Side Bull On Strong Growth Forecast
Monday, May 14, 2018 - 2:00pm | 375Read More...FMC Corp (NYSE: FMC) acquired a portion of DowDuPont Inc (NYSE: DWDP)'s crop protection business and sold its health and nutrition business to DowDuPont in November. The chemical manufacturer reported first-quarter results May 2 that included EPS and sales beats. The Analyst Goldman...
-
Newly Merged DowDuPont Gets A Bullish Call From Goldman
Tuesday, December 5, 2017 - 10:13am | 524Read More...DowDuPont Inc (NYSE: DWDP) was formed due to the recent merger between Dow Chemical Co (NYSE: DOW) and E I Du Pont De Nemours And Co (NYSE: DD). The merger was completed Aug. 31, 2017. About three months into DowDuPont's existence as a merged entity, Goldman issued a bullish call on the...
-
PPG Industries Removed From Goldman's Buy List, Downgraded To Neutral Citing No Near-Term Catalysts
Friday, October 21, 2016 - 8:41am | 344Read More...The negative preannouncement by PPG Industries, Inc. (NYSE: PPG) on October 7, which was the first in eight years, had an adverse impact on investors who have become accustomed to a “defensive earnings base and stable DD EPS growth.” Goldman Sachs’ Robert Koort downgraded the...
-
PPG Industries Shares Worth Another Look After Recent Selloff
Wednesday, October 12, 2016 - 3:09pm | 224Read More...Goldman Sachs says the 10 percent selloff in PPG Industries, Inc. (NYSE: PPG) shares after negative pre-announcement and the de-risking of FY 2017 sell-side estimates makes PPG compelling at current levels. The company expects third quarter EPS of $1.52-$1.54 versus Street at $1.71, attributed...
-
Goldman Reinstate Coverage On Westlake Chemical, Sees 3% Downside
Friday, September 30, 2016 - 10:09am | 262Read More...Goldman Sachs reinstated coverage of Westlake Chemical Corporation (NYSE: WLK) at Neutral with a $51 target price. The brokerage said the acquisition of PVC producer Axiall Corporation makes strategic sense for Westlake by shifting exposure to a potential chlor-alkali upcycle from declining U.S...
-
Organic Growth For PolyOne Remains Elusive, Says Goldman
Thursday, July 28, 2016 - 11:59am | 284Read More...Goldman Sachs has downgraded PolyOne Corporation (NYSE: POL) to Neutral from Buy, saying that the "organic growth remains elusive" for the provider of polymer materials, services and solutions. The downgrade comes despite the company's second-quarter EPS of $0.63 topped consensus estimate of $0.61...
-
Univar Spikes 6% Following Goldman's Buy Upgrade
Wednesday, May 11, 2016 - 2:37pm | 242Read More...Goldman Sachs' Robert Koort upgraded Univar Inc (NYSE: UNVR) from Neutral to Buy, ripping the stock price ups by 6 percent. Koort raised the price target to $22 from $18. Koort felt Univar is "primed to benefit from a rejuvenated growth story as oil&gas headwinds subside."...
-
The Best Way To Play Electric Vehicles That's Not Tesla
Monday, April 25, 2016 - 9:42am | 339Read More...Battery demand for electric vehicles, including the latest model from Tesla Motors Inc (NASDAQ: TSLA), is expected to significantly boost lithium demand. Goldman Sachs’ Robert Koort projected a threefold increase in lithium demand by 2025, mainly due to its use in batteries, which is...
-
Goldman Removes W. R. Grace From America's Buy List, Downgrades To Neutral
Monday, March 14, 2016 - 10:30am | 223Read More...Goldman Sachs’ Robert Koort downgraded the rating on W. R. Grace & Co (NYSE: GRA) from Buy to Neutral, with a price target of $77. Upside Potential While mentioning that more consumer-oriented and deep cyclical companies in Goldman Sachs’ coverage had more upside, Koort...
-
Goldman Upgrades Chemours To Buy
Monday, March 14, 2016 - 9:54am | 259Read More...Goldman Sachs’ Robert Koort upgraded the rating for Chemours Co (NYSE: CC) from Neutral to Buy, while raising the price target from $6 to $10. The analyst cited substantial cyclical upside as well as cost controls as the reasons for the revisions. Since June 2015, Chemours’ shares...
-
Goldman Downgrades Ecolab To Sell
Monday, March 14, 2016 - 9:38am | 202Read More...Goldman Sachs’ Robert Koort downgraded the rating for Ecolab Inc. (NYSE: ECL) from Neutral to Sell, while reducing the price target from $104 to $93, citing the company’s moderating earnings growth. Cyclical Headwinds In Energy Business Warrant Lower Valuation Analyst Robert Koort...
-
Goldman Warns Of Monsanto Sell, At Odds With Wall Street
Friday, March 4, 2016 - 9:55am | 262Read More...Goldman Sachs’ Robert Koort downgraded the rating for Monsanto Company (NYSE: MON) from Neutral to Sell, while reducing the price target from $86 to $84. The recommendation of Sell comes even while most of Wall Street, including Deutsche Bank, Credit Suisse, Atlantic, Piper Jaffray,...
-
Calls of Note: The Research Notes Moving The Market This Monday
Monday, August 17, 2015 - 1:09pm | 1211Read More...The following represents a hand-picked selection of notable research curated by an analyst known in some circles as "The Sith Overlord Of The Street." Pacific Crest: It's ‘OK' Apple iPhone Units Might Decline Next Year Andy Hargreaves of Pacific Crest believes that Apple Inc. (NASDAQ: AAPL) will...
-
Goldman Sachs: Polyone Has 22% Return Potential
Monday, August 17, 2015 - 8:12am | 328Read More...In a report published Monday, Goldman Sachs analyst Robert Koort upgraded the rating on PolyOne Corporation (NYSE: POL), while raising the price target from $37 to $41. The analyst believes that the stock offer 22 percent return potential. "POL shares have suffered the last few months...
